Skip to main content
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 1996 Apr;22(2):105–110. doi: 10.1136/jme.22.2.105

Genetic testing and early diagnosis and intervention: boon or burden?

E R Hepburn 1
PMCID: PMC1376924  PMID: 8731537

Abstract

The possibility of early diagnosis and intervention is radically changed by the advent of genetic testing. The recent report of the Nuffield Council on Bioethics is timely and helpful. I have suggested, that not only the severity of the disability indicated by genetic information, and the accuracy of the data, ought to govern the approach to the implementation of screening for genetic disorders. In addition, assessment of the value of the information to those involved should be considered. The efficacy of the available therapeutic measures, combined with the prognostic data are important indices of the value of the information. These measures fall into three categories and thus indicate that three different courses of intervention may be appropriate. Three approaches to diagnosis and intervention are then outlined, drawing on the experience of various clinical initiatives.

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Easton D. F., Bishop D. T., Ford D., Crockford G. P. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1993 Apr;52(4):678–701. [PMC free article] [PubMed] [Google Scholar]
  2. Fletcher J. C. Ethical issues in genetic screening and antenatal diagnosis. Clin Obstet Gynecol. 1981 Dec;24(4):1151–1168. doi: 10.1097/00003081-198112000-00012. [DOI] [PubMed] [Google Scholar]
  3. Ford D., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994 Mar 19;343(8899):692–695. doi: 10.1016/s0140-6736(94)91578-4. [DOI] [PubMed] [Google Scholar]
  4. Leary Virginia A. The right to health in international human rights law. Health Hum Rights. 1994 Fall;1(1):24–56. [PubMed] [Google Scholar]
  5. Meador C. K. The last well person. N Engl J Med. 1994 Feb 10;330(6):440–441. doi: 10.1056/NEJM199402103300618. [DOI] [PubMed] [Google Scholar]
  6. Zeesman S., Clow C. L., Cartier L., Scriver C. R. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Am J Med Genet. 1984 Aug;18(4):769–778. doi: 10.1002/ajmg.1320180424. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES